form424b7.htm
Filed
Pursuant to Rule 424(b)(7)
Registration
No. 333- 151811
PROSPECTUS
SUPPLEMENT NO. 8
To
prospectus dated June 20, 2008
Class
A Common Stock
This
prospectus supplement no. 8, which supplements the prospectus dated and filed on
June 20, 2008, prospectus supplement no. 1 dated and filed on July 11, 2008,
prospectus supplement no. 2 dated and filed on August 7, 2008, prospectus
supplement no. 3 dated and filed on September 5, 2008, prospectus supplement no.
4 dated and filed on October 7, 2008, prospectus supplement no. 5 dated and
filed on November 19, 2008, prospectus supplement no. 6 dated and filed on
December 18, 2008 and prospectus supplement no. 7 dated and filed on January 30,
2009, relates to the resale from time to time by selling shareholders of shares
of our Class A common stock that we may issue to them upon the conversion of our
3.50% Senior Convertible Notes due 2013, or the “notes”.
You
should read this prospectus supplement in conjunction with the related
prospectus, and related prospectus supplements nos. 1, 2, 3, 4, 5, 6 and 7. This
prospectus supplement is not complete without, and may not be delivered or used
except in conjunction with, the prospectus, including any amendments or
supplements to the prospectus. This prospectus supplement is qualified by
reference to the prospectus, and prospectus supplements nos. 1, 2, 3, 4, 5, 6
and 7, except to the extent that the information provided by this prospectus
supplement supersedes or supplements
information contained in the prospectus or in prospectus supplements nos.
1, 2, 3, 4, 5, 6 or 7.
Neither
the Securities and Exchange Commission nor any state securities commission has
approved or disapproved of these securities or determined if this prospectus is
truthful or complete. Any representation to the contrary is a
criminal offense.
The
date of this prospectus supplement is March 13, 2009.
SELLING
SHAREHOLDERS
The table
of selling shareholders appearing under the caption “Selling Shareholders” beginning on page 5 of the prospectus dated June
20, 2008, and the table of selling shareholders appearing
under the caption “Selling Shareholders” in
prospectus supplements nos. 1, 2, 3, 4, 5, 6 and 7 are hereby supplemented and amended by adding to
them
the information regarding certain selling shareholders set forth below.
Where the name of a selling shareholder identified in the table below also
appears in the table in the prospectus, or in the table in prospectus
supplements nos. 1, 2, 3, 4, 5, 6 or 7, the information set forth below
regarding such selling shareholder supersedes and replaces the information in
the prospectus, and in prospectus supplements nos. 1, 2, 3, 4, 5, 6 and
7.
The
information set forth below is based on information provided by or on behalf of
the selling shareholders to us in a selling shareholder questionnaire and is as
of the date specified by the selling shareholders in such
questionnaires. The selling shareholders identified below, or those
listed in the prospectus dated June 20, 2008, or prospectus supplements nos. 1,
2, 3, 4, 5, 6 or 7 may have sold, transferred or otherwise disposed of all
or a portion of their notes or the shares of Class A common stock issuable upon
conversion of the notes since the date on which they provided the
information.
|
|
Number
of Shares Beneficially Owned Prior to Offering(2)
|
|
|
Number
of Shares of Common Stock That May Be Sold Pursuant to this
Prospectus(2)
|
|
|
Number
of Shares Beneficially Owned After Offering
|
|
|
Percentage
of Outstanding Class A Common Stock Beneficially Owned After
Offering(3)
|
|
MacKay
Shields LLC (4)
|
|
105,247
|
|
|
105,247
|
|
|
–
|
|
|
*
|
|
(1)
Information regarding the selling shareholders may change from time to time. Any
such changed information will be set forth in supplements to this prospectus if
legally required.
(2)
Assumes for each $1,000 in principal amount of notes a maximum of 9.5238 shares
of Class A common stock will be received upon conversion. This
conversion rate is subject to adjustment as described in the Indenture among us,
Central European Media Enterprises N.V., CME Media Enterprises B.V. and The Bank
of New York, dated March 10, 2008, a copy of which is filed as an exhibit to our
Quarterly Report on Form 10-Q for the quarter ended March 31, 2008, incorporated
herein by reference. As a result, the number of shares of Class A common stock
issuable upon conversion of the notes may increase or decrease in the
future. We will not issue
fractional shares of our Class A common stock upon conversion of the notes.
Instead, we will pay cash in lieu of
fractional shares based on the volume weighted average price per share of
our Class A common stock on the final settlement period trading day of the
applicable conversion period (or in the case of settlement in shares of
Class A common stock only, the
conversion period that would be applicable if settlement were in cash and, if
applicable, shares of our Class A common stock).
(3)
Calculated based on 36,024,273 shares of Class A common stock outstanding as of
February 20, 2009. In calculating this amount for each holder,
we treated as outstanding the number of shares of Class A common stock issuable
upon conversion of all of that holder’s notes, but we did not assume conversion
of any other holder’s notes. The beneficial ownership in this column assumes
that the selling stockholder sells all of the shares offered by this prospectus
issuable upon the conversion of the notes that are beneficially owned by the
selling stockholder as of the date of this prospectus.
(4)
NYLIFE Securities Inc. and NYLIFE Distributors LLC are registered broker-dealers
and, like the selling shareholder, are indirect wholly-owned subsidiaries of New
York Life Insurance Company. The selling shareholder has certified that it
acquired the notes in the ordinary course of business and that at the time of
the purchase of the notes, it did not have any agreements or understandings,
directly or indirectly, with any person to distribute the notes. The pecuniary
interests in the shares are held by a number of clients for whom the selling
shareholder is the discretionary investment advisor or sub-advisor. Such clients
have granted the selling shareholder the authority to vote their shares. Edward
Silverstein, a Managing Director of the selling shareholder, has voting and
dispositive powers over the shares offered by the selling
shareholder.